North America Disposable Endoscopes Market To Reach $2.01 Billion By 2030

North America Disposable Endoscopes Market Growth & Trends

The global North America disposable endoscopes market size is expected to reach USD 2.01 billion by 2030, registering a CAGR of 7.85% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of infection due to reusable endoscopes in the hospitals and the growing preference for disposable endoscope components are some of the major factors anticipated to drive the market growth over the forecast years. In addition, cleaning and disinfecting disposable endoscopes and their accessories to eliminate the disease transmission risk is a very tedious task for medical professionals.

The increasing number of endoscopic procedures and the growing prevalence of several chronic diseases are also further expected to accelerate the market growth. The lack of reprocessing and drying practices by the medical staff increases the chance of contamination which in turn drives the single-use endoscopes adoption. For instance, the data published in the American Journal of Infection Control stated that about 71% of the reusable endoscopes sample found microbial growth. The bronchoscopy segment dominated the market by application in 2021 with a revenue share of 29.3%. Flexible bronchoscopes play a critical role in the therapeutic and diagnostic management of several pulmonary disorders and better procedural outcomes.

The growing adoption of bronchoscopes for the diagnosis of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is expected to drive the segment growth. Increasing COVID-19 cases and the fear of disease transmission due to the use of reusable bronchoscopes also boosted the single-use bronchoscope adoption. For instance, according to World Health Organization (WHO), the number of COVID-19 cases has increased to over 74.8 million by February 2022 in the United States of America. The hospital segment dominated the market and accounted for a revenue share of 47.5% in 2021 owing to the increasing number of endoscopic procedures performed in the hospitals and growing patient preference to visit the hospital for disease diagnosis.

However, the fastest growth is expected from the clinics segment over the forecast period owing to the increasing preference to use single-use endoscopic devices to reduce the risk of contamination, lower the procedure cost, and better clinical outcomes. In addition, an increasing number of clinics that performed endoscopic procedures in the U.S also anticipated supporting high growth of the segment. The COVID-19 pandemic has positively impacted the growth of the market. The benefit of using a disposable endoscope to minimize the risk of disease transmission increased its adoption during the COVID-19 period.

Increasing regulatory approval and strategic initiatives by the manufacturers to innovate new endoscopic devices to meet the consumer's needs, in turn, supported the growth of the market. For instance, in July 2020 a medical device manufacturer, Ambu Inc., got U.S. FDA 510(k) approval for its sterile single-use duodenoscope device. The device includes “aScope Duodeno” which is a single-use endoscope and “aBox Duodeno" a reusable processor unit to treat and diagnose several disease conditions like cancer, tumors, pancreatitis, and gallstones, in the bile duct and pancreas.

 Request a free sample copy or view the report summary: North America Disposable Endoscopes Market Report

North America Disposable Endoscopes Market Report Highlights

• The gastrointestinal endoscopes segment dominated the market with revenue share of 56.6% in 2024. The U.S. dominated the disposable endoscopes market in North America in 2024.

• The laparoscopes segment is expected to witness fastest CAGR growth during the forecast period. The U.S. FDA recently approved various disposable bronchoscopes, which are anticipated to increase the availability of these devices in the market and drive segment growth.

• The outpatient facilities’ segment dominated the market in 2024 and accounted for the largest revenue share of 53.3%. Favorable government initiatives and reimbursement policies boost the segment growth.

North America Disposable Endoscopes Market Segmentation

Grand View Research has segmented the North America disposable endoscopes market on the basis of on type, end-use, and country:

North America Disposable Endoscopes Type Outlook (Revenue, USD Million, 2018 - 2030)

• Laparoscopes

• Arthroscopes

• Ureteroscopes

• Cystoscopes

• Gynecology Endoscopes

• Neuroendoscopes

• Bronchoscopes

• Hysteroscopes

• Laryngoscopes

• Otoscopes

• Nasopharyngoscopes

• Rhinoscopes

• Gastrointestinal Endoscopes

• Gastroscope (Upper GI Endoscope)

• Enteroscope

• Sigmoidoscope

• Duodenoscope

• Colonoscope

North America Disposable Endoscopes End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Outpatient facilities

North America Disposable Endoscopes Country Outlook (Revenue, USD Million, 2018 - 2030)

• North America

• U.S.

• Canada

• Mexico

List of Key Players in the North America Disposable Endoscopes Market

• Olympus Corporation

• Boston Scientific Corporation

• PENTAX Medical (Hoya Corporation)

• FUJIFILM Holdings Corporation

• Karl Storz GmbH & Co., KG

• Stryker

• Medtronic

• Ambu A/S

• STERIS plc.